In honor of National Kidney and Autoimmune Disease month, Myrah Lykes, CEO & founder of Steps 2 Destiny is hosting a symposium next weekend. It’s happening at the Hilton Garden Inn ...
Chronic inflammatory demyelinating polyradiculoneuropathy is a rare autoimmune-related condition that affects nerve signaling ...
During Autoimmune Disease Awareness Month, Clayman Thyroid Center will observe the second annual Hashimoto’s Disease Awareness Day on March 11 — a national initiative launched in 2025 to elevate ...
A new approach targets the B-cell pathway with bispecific antibodies, building on decades of research that establishes the role of B cells and self-reactive antibodies in lupus, systemic sclerosis, ...
Scientists are trying a revolutionary new approach to treat rheumatoid arthritis, multiple sclerosis, lupus and other devastating autoimmune diseases — by reprogramming patients’ out-of-whack immune ...
This is read by an automated voice. Please report any issues or inconsistencies here. People with autoimmune illnesses often struggle for years to get a diagnosis and to find doctors who take their ...
A “living drug” was developed as a cancer treatment. Now it is showing promise for conditions, such as lupus and multiple sclerosis, that have long been considered incurable.
Scientists are trying a revolutionary new approach to treat rheumatoid arthritis, multiple sclerosis, lupus and other devastating autoimmune diseases – by reprogramming patients’ out-of-whack immune ...
Autoimmune diseases share the same core pathology despite their differing clinical manifestations: dysregulated B and T cell activity. B cells contribute to disease progression by secreting ...
Scientists are trying a revolutionary new approach to treat rheumatoid arthritis, multiple sclerosis, lupus and other devastating autoimmune diseases — by reprogramming patients' out-of-whack immune ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results